Literature DB >> 20809426

Prognostic significance of response to preoperative radiotherapy, lymph node metastasis, and CEA level in patients undergoing total mesorectal excision of rectal cancer.

Soichiro Ishihara1, Toshiaki Watanabe, Tomomichi Kiyomatsu, Koji Yasuda, Hirokazu Nagawa.   

Abstract

PURPOSE: The aim of this study was to investigate the prognostic significance of the response of primary rectal lesions to preoperative radiotherapy, pathological nodal status, and carcinoembryonic antigen (CEA) levels before and after radiotherapy in rectal cancer patients treated with a total mesorectal excision.
METHODS: We investigated the prognostic significance of the clinical and pathological factors in 97 patients treated with preoperative radiotherapy (50-50.4 Gy over 5-6 weeks) followed by curative resections.
RESULTS: A high CEA level (>5 ng/mL) after radiotherapy (hazard ratio, 2.849; 95% confidence interval, 1.061-7.651; p = 0.0377) and pathological lymph node metastasis (hazard ratio, 0.350; 95% confidence interval, 0.154-0.797; p = 0.0124) were independently associated with postoperative recurrence. Although the CEA level before radiotherapy was associated with disease-free survival in a univariate analysis, it lost its statistical significance in a multivariate analysis. The response of the primary rectal lesions, evaluated pathologically by T stage and the degree of regression, was not associated with disease-free survival. In patients without lymph node metastasis, the 5-year disease-free survival of those with a high CEA level after radiotherapy was significantly worse than those with low CEA after radiotherapy (61.6% vs. 89.0%, respectively, p = 0.0234).
CONCLUSIONS: Pathological lymph node metastasis and a high CEA level after radiotherapy were independent predictors of a poor outcome in rectal cancer patients treated with preoperative radiotherapy. The CEA level after radiotherapy was capable of discriminating patients with a high risk of recurrence among pathologically node-negative patients.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20809426     DOI: 10.1007/s00384-010-1051-1

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  34 in total

1.  The 4-portal technique decreases adverse effects in preoperative radiotherapy for advanced rectal cancer: comparison between the 2-portal and the 4-portal techniques.

Authors:  Tomomichi Kiyomatsu; Toshiaki Watanabe; Tetsuichiro Muto; Hirokazu Nagawa
Journal:  Am J Surg       Date:  2007-10       Impact factor: 2.565

2.  Improved survival with preoperative radiotherapy in resectable rectal cancer.

Authors:  B Cedermark; M Dahlberg; B Glimelius; L Påhlman; L E Rutqvist; N Wilking
Journal:  N Engl J Med       Date:  1997-04-03       Impact factor: 91.245

3.  Preoperative short-term radiation therapy in operable rectal carcinoma. A prospective randomized trial. Stockholm Rectal Cancer Study Group.

Authors: 
Journal:  Cancer       Date:  1990-07-01       Impact factor: 6.860

4.  Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.

Authors:  Claus Rödel; Peter Martus; Thomas Papadoupolos; Laszlo Füzesi; Martin Klimpfinger; Rainer Fietkau; Torsten Liersch; Werner Hohenberger; Rudolf Raab; Rolf Sauer; Christian Wittekind
Journal:  J Clin Oncol       Date:  2005-10-24       Impact factor: 44.544

Review 5.  Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999.

Authors:  C C Compton; L P Fielding; L J Burgart; B Conley; H S Cooper; S R Hamilton; M E Hammond; D E Henson; R V Hutter; R B Nagle; M L Nielsen; D J Sargent; C R Taylor; M Welton; C Willett
Journal:  Arch Pathol Lab Med       Date:  2000-07       Impact factor: 5.534

6.  Prognostic effect of perioperative change of serum carcinoembryonic antigen level: a useful tool for detection of systemic recurrence in rectal cancer.

Authors:  Yoon-Ah Park; Kang Young Lee; Nam Kyu Kim; Seung Hyuk Baik; Seung Kook Sohn; Chang Whan Cho
Journal:  Ann Surg Oncol       Date:  2006-03-13       Impact factor: 5.344

7.  Pathologic response assessed by Mandard grade is a better prognostic factor than down staging for disease-free survival after preoperative radiochemotherapy for advanced rectal cancer.

Authors:  J Suárez; R Vera; E Balén; M Gómez; F Arias; J M Lera; J Herrera; C Zazpe
Journal:  Colorectal Dis       Date:  2007-12-07       Impact factor: 3.788

8.  Long-term efficacy of preoperative radiotherapy for locally advanced low rectal cancer.

Authors:  Shingo Tsujinaka; Yutaka J Kawamura; Fumio Konishi; Hiroyuki Aihara; Takafumi Maeda; Ken Mizokami
Journal:  Int J Colorectal Dis       Date:  2007-08-18       Impact factor: 2.571

9.  Initial report from a Swedish multicentre study examining the role of preoperative irradiation in the treatment of patients with resectable rectal carcinoma. Swedish Rectal Cancer Trial.

Authors: 
Journal:  Br J Surg       Date:  1993-10       Impact factor: 6.939

10.  Prognostic value of postoperative CEA clearance in rectal cancer patients with high preoperative CEA levels.

Authors:  Jeong Yeon Kim; Nam Kyu Kim; Seung Kook Sohn; Yong Wan Kim; Kim Jin Soo Kim; Hyuk Hur; Byung Soh Min; Chang Hwan Cho
Journal:  Ann Surg Oncol       Date:  2009-08-06       Impact factor: 5.344

View more
  8 in total

Review 1.  Distal dissection in total mesorectal excision, and preoperative chemoradiotherapy and lateral lymph node dissection for rectal cancer.

Authors:  Jin-ichi Hida; Kiyotaka Okuno; Tadao Tokoro
Journal:  Surg Today       Date:  2013-12-22       Impact factor: 2.549

Review 2.  Biomarkers for predicting future metastasis of human gastrointestinal tumors.

Authors:  Lui Ng; Ronnie Tung Ping Poon; Roberta Pang
Journal:  Cell Mol Life Sci       Date:  2013-01-31       Impact factor: 9.261

3.  STAT3 inhibition sensitizes colorectal cancer to chemoradiotherapy in vitro and in vivo.

Authors:  Melanie Spitzner; Birte Roesler; Christian Bielfeld; Georg Emons; Jochen Gaedcke; Hendrik A Wolff; Margret Rave-Fränk; Frank Kramer; Tim Beissbarth; Julia Kitz; Jürgen Wienands; B Michael Ghadimi; Reinhard Ebner; Thomas Ried; Marian Grade
Journal:  Int J Cancer       Date:  2013-09-03       Impact factor: 7.396

4.  Survival implications of pretreatment pelvic CT in rectal cancer patients after neoadjuvant chemoradiotherapy and surgery.

Authors:  Chunyan Cui; Min Zhang; Li Tian; Wu Jiang; Zhifang Zeng; Li Li
Journal:  Int J Clin Exp Med       Date:  2015-08-15

5.  Identification of a DNA methylation signature to predict disease-free survival in locally advanced rectal cancer.

Authors:  Jochen Gaedcke; Andreas Leha; Rainer Claus; Dieter Weichenhan; Klaus Jung; Julia Kitz; Marian Grade; Hendrik A Wolff; Peter Jo; Jérôme Doyen; Jean-Pierre Gérard; Steven A Johnsen; Christoph Plass; Tim Beißbarth; Michael Ghadimi
Journal:  Oncotarget       Date:  2014-09-30

6.  The combination of early treatment response and ypT stage is a novel metric to stage rectal cancer patients treated with neoadjuvant chemoradiotherapy.

Authors:  Jian Cui; Lin Yang; Lei Guo; Yongfu Shao; Dongfeng Tan; Ni Li; Haizeng Zhang
Journal:  Oncotarget       Date:  2017-06-06

7.  Carcinoembryonic antigen (CEA) level, CEA ratio, and treatment outcome of rectal cancer patients receiving pre-operative chemoradiation and surgery.

Authors:  Kai-Lin Yang; Shung-Haur Yang; Wen-Yih Liang; Ying-Ju Kuo; Jen-Kou Lin; Tzu-Chen Lin; Wei-Shone Chen; Jeng-Kae Jiang; Huann-Sheng Wang; Shih-Ching Chang; Lee-Shing Chu; Ling-Wei Wang
Journal:  Radiat Oncol       Date:  2013-03-01       Impact factor: 3.481

8.  Carcinoembryonic antigen as a marker of radioresistance in colorectal cancer: a potential role of macrophages.

Authors:  Eng-Yen Huang; Jen-Chieh Chang; Hong-Hwa Chen; Chieh-Ying Hsu; Hsuan-Chih Hsu; Keng-Liang Wu
Journal:  BMC Cancer       Date:  2018-03-27       Impact factor: 4.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.